Researcher Profiles

Return to member profile

Sung Kim, MD

Publications since 2011

Kim, S. Head and Neck Radiation Oncology: Is Busier Better? J Clin Oncol, In process, . (PMID: 26729436)

Jabbour, S. K. Kim, S. Haider, S. A. Xu, X. Wu, A. Surakanti, S. Aisner, J. Langenfeld, J. Yue, N. J. Haffty, B. G. Zou, W. Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy. Int J Radiat Oncol Biol Phys, 92:627-633, . (PMID: 26068495)

Lu-Yao, G. L. Kim, S. Moore, D. F. Shih, W. Lin, Y. DiPaola, R. S. Shen, S. Zietman, A. Yao, S. L. Primary radiotherapy vs conservative management for localized prostate cancer-a population-based study. Prostate Cancer Prostatic Dis, In process, . (PMID: 26101187)

Kang, J. H. Ha, Y. S. Kim, S. Yu, J. Patel, N. Parihar, J. S. Salmasi, A. H. Kim, W. J. Kim, I. Y. Concern for overtreatment using the AUA/ASTRO guideline on adjuvant radiotherapy after radical prostatectomy. BMC Urol, 14:30, . (PMID: 24708639, PMCID: PMC4005471)

Shao, Y. H. Kim, S. Moore, D. F. Shih, W. Lin, Y. Stein, M. Kim, I. Y. Lu-Yao, G. L. Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score-Matched Analysis. Eur Urol, In process, . (PMID: 23759328)

Zhang, M. Qin, S. Chen, T. Kim, S. Jabbour, S. Haffty, B. Yue, N. J. A Clinical Objective IMRT QA Method Based on Portal Dosimetry and Electronic Portal Imager Device (EPID) Measurement. Technol Cancer Res Treat, 12:145-150, . (PMID: 23289479)

Kim, S. Moore, D. F. Shih, W. Lin, Y. Li, H. Shao, Y. H. Shen, S. Lu-Yao, G. L. Severe Genitourinary Toxicity Following Radiation Therapy for Prostate Cancer-How Long Does it Last? J Urol, 189:116-121, . (PMID: 23164376)

Qin, S. Zhang, M. Kim, S. Chen, T. Kim, L. H. Haffty, B. G. Yue, N. J. A systematic approach to statistical analysis in dosimetry and patient-specific IMRT plan verification measurements. Radiat Oncol, 8:225, . (PMID: 24074185, PMCID: PMC3852372)

Yue, N. J. Patel, A. N. Haffty, B. G. Kim, S. Efficacy of fiducial marker-based image-guided radiation therapy in prostate tomotherapy and potential dose coverage improvement using a patient positioning optimization method. Pract Radiat Oncol, 2:138-144, . (PMID: 24674089)

Chowdhury, N. Toth, R. Chappelow, J. Kim, S. Motwani, S. Punekar, S. Lin, H. Both, S. Vapiwala, N. Hahn, S. Madabhushi, A. Concurrent segmentation of the prostate on MRI and CT via linked statistical shape models for radiotherapy planning. Med Phys, 39:2214-2228, . (PMID: 22482643, PMCID: PMC3337664)

Patel, A. N. Mehnert, J. M. Kim, S. Treatment of recurrent metastatic head and neck cancer: focus on cetuximab. Clin Med Insights Ear Nose Throat, 5:1-16, . (PMID: 24179404, PMCID: PMC3791949)

Kim, S. Shen, S. Moore, D. F. Shih, W. Lin, Y. Li, H. Dolan, M. Shao, Y. H. Lu-Yao, G. L. Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur Urol, 60:908-916, . (PMID: 21684064, PMCID: PMC3185133)

Kim, Y. J. Yoon, H. Y. Kim, S. K. Kim, Y. W. Kim, E. J. Kim, I. Y. Kim, W. J. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling. Clin Cancer Res, 17:4523-4530, . (PMID: 21571867)

Raldow, A. Hamstra, D. A. Kim, S. N. Yu, J. B. Adjuvant radiotherapy after radical prostatectomy: evidence and analysis. Cancer Treat Rev, 37:89-96, . (PMID: 20667660)

Kim, S. Eleff, M. Nicolaou, N. Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck. Head Neck, 33:286-288, . (PMID: 19953623)